Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 577 to 584 of 584 entries
Sorted by: Best Match Show Resources per page
Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome.

Open heart

Eastwood K, Howell S, Nehme Z, Finn J, Smith K, Cameron P, Stub D, Bray JE.
PMID: 34663748
Open Heart. 2021 Oct;8(2). doi: 10.1136/openhrt-2021-001792.

OBJECTIVE: Between 2009 and 2013, the National Heart Foundation of Australia ran mass media campaigns to improve Australian's awareness of acute coronary syndrome (ACS) symptoms and the need to call emergency medical services (EMS). This study examined the impact...

Cite
Eastwood K, Howell S, Nehme Z, et al. Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome. Open Heart. 2021;8(2)doi: 10.1136/openhrt-2021-001792.
Eastwood, K., Howell, S., Nehme, Z., Finn, J., Smith, K., Cameron, P., Stub, D., & Bray, J. E. (2021). Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome. Open heart, 8(2), . https://doi.org/10.1136/openhrt-2021-001792
Eastwood, Kathryn, et al. "Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome." Open heart vol. 8,2 (2021). doi: https://doi.org/10.1136/openhrt-2021-001792
Eastwood K, Howell S, Nehme Z, Finn J, Smith K, Cameron P, Stub D, Bray JE. Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome. Open Heart. 2021 Oct;8(2). doi: 10.1136/openhrt-2021-001792. PMID: 34663748; PMCID: PMC8524379.
Copy Download .nbib Format: NLM
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.

Lancet (London, England)

Stuart ASV, Shaw RH, Liu X, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, England A, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Horsington BM, Lambe T, Lazarus R, Libri V, Lillie PJ, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, Vichos I, White R, Nguyen-Van-Tam JS, Snape MD.
PMID: 34883053
Lancet. 2021 Dec 06; doi: 10.1016/S0140-6736(21)02718-5. Epub 2021 Dec 06.

BACKGROUND: Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied mixed priming schedules incorporating an adenoviral-vectored vaccine (ChAdOx1 nCoV-19 [ChAd], AstraZeneca), two mRNA vaccines (BNT162b2 [BNT], Pfizer-BioNTech, and...

Cite
Stuart ASV, Shaw RH, Liu X, et al. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Lancet. 2021;doi: 10.1016/S0140-6736(21)02718-5.
Stuart, A. S. V., Shaw, R. H., Liu, X., Greenland, M., Aley, P. K., Andrews, N. J., Cameron, J. C., Charlton, S., Clutterbuck, E. A., Collins, A. M., Darton, T., Dinesh, T., Duncan, C. J. A., England, A., Faust, S. N., Ferreira, D. M., Finn, A., Goodman, A. L., Green, C. A., Hallis, B., Heath, P. T., Hill, H., Horsington, B. M., Lambe, T., Lazarus, R., Libri, V., Lillie, P. J., Mujadidi, Y. F., Payne, R., Plested, E. L., Provstgaard-Morys, S., Ramasamy, M. N., Ramsay, M., Read, R. C., Robinson, H., Screaton, G. R., Singh, N., Turner, D. P. J., Turner, P. J., Vichos, I., White, R., Nguyen-Van-Tam, J. S., Snape, M. D. (2021). Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Lancet (London, England), . https://doi.org/10.1016/S0140-6736(21)02718-5
Stuart, Arabella S V, et al. "Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial." Lancet (London, England) vol. (2021). doi: https://doi.org/10.1016/S0140-6736(21)02718-5
Stuart ASV, Shaw RH, Liu X, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, England A, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Horsington BM, Lambe T, Lazarus R, Libri V, Lillie PJ, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, Vichos I, White R, Nguyen-Van-Tam JS, Snape MD. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Lancet. 2021 Dec 06; doi: 10.1016/S0140-6736(21)02718-5. Epub 2021 Dec 06. PMID: 34883053; PMCID: PMC8648333.
Copy Download .nbib Format: NLM
Daily Training efficiency during computerized cognitive rehabilitation training (CCRT): an analysis from a randomized trial in Ugandan children with and without severe malaria.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence

Larrivey V, Neva J, Finn K, Sikorskii A, Familiar-Lopez I, Ucheagwu V, Ezeamama A, Ruisenor-Escudero H, Nakasujja N, Boivin M, Giordani B.
PMID: 34380364
Child Neuropsychol. 2021 Aug 11;1-15. doi: 10.1080/09297049.2021.1962266. Epub 2021 Aug 11.

Children in Uganda are at risk for significant cognitive sequelae from severe malaria. Computerized cognitive rehabilitation training (CCRT) represents a potential method to improve working memory, behavior, and executive functioning, cognitive domains most at risk following severe malaria. The...

Cite
Larrivey V, Neva J, Finn K, et al. Daily Training efficiency during computerized cognitive rehabilitation training (CCRT): an analysis from a randomized trial in Ugandan children with and without severe malaria. Child Neuropsychol. 2021;1-15doi: 10.1080/09297049.2021.1962266.
Larrivey, V., Neva, J., Finn, K., Sikorskii, A., Familiar-Lopez, I., Ucheagwu, V., Ezeamama, A., Ruisenor-Escudero, H., Nakasujja, N., Boivin, M., & Giordani, B. (2021). Daily Training efficiency during computerized cognitive rehabilitation training (CCRT): an analysis from a randomized trial in Ugandan children with and without severe malaria. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence, 1-15. https://doi.org/10.1080/09297049.2021.1962266
Larrivey, Valentina, et al. "Daily Training efficiency during computerized cognitive rehabilitation training (CCRT): an analysis from a randomized trial in Ugandan children with and without severe malaria." Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence vol. (2021): 1-15. doi: https://doi.org/10.1080/09297049.2021.1962266
Larrivey V, Neva J, Finn K, Sikorskii A, Familiar-Lopez I, Ucheagwu V, Ezeamama A, Ruisenor-Escudero H, Nakasujja N, Boivin M, Giordani B. Daily Training efficiency during computerized cognitive rehabilitation training (CCRT): an analysis from a randomized trial in Ugandan children with and without severe malaria. Child Neuropsychol. 2021 Aug 11;1-15. doi: 10.1080/09297049.2021.1962266. Epub 2021 Aug 11. PMID: 34380364.
Copy Download .nbib Format: NLM
RosBREED: bridging the chasm between discovery and application to enable DNA-informed breeding in rosaceous crops.

Horticulture research

Iezzoni AF, McFerson J, Luby J, Gasic K, Whitaker V, Bassil N, Yue C, Gallardo K, McCracken V, Coe M, Hardner C, Zurn JD, Hokanson S, van de Weg E, Jung S, Main D, da Silva Linge C, Vanderzande S, Davis TM, Mahoney LL, Finn C, Peace C.
PMID: 33328430
Hortic Res. 2020 Nov 01;7(1):177. doi: 10.1038/s41438-020-00398-7.

The Rosaceae crop family (including almond, apple, apricot, blackberry, peach, pear, plum, raspberry, rose, strawberry, sweet cherry, and sour cherry) provides vital contributions to human well-being and is economically significant across the U.S. In 2003, industry stakeholder initiatives prioritized...

Cite
Iezzoni AF, McFerson J, Luby J, et al. RosBREED: bridging the chasm between discovery and application to enable DNA-informed breeding in rosaceous crops. Hortic Res. 2020;7(1):177doi: 10.1038/s41438-020-00398-7.
Iezzoni, A. F., McFerson, J., Luby, J., Gasic, K., Whitaker, V., Bassil, N., Yue, C., Gallardo, K., McCracken, V., Coe, M., Hardner, C., Zurn, J. D., Hokanson, S., van de Weg, E., Jung, S., Main, D., da Silva Linge, C., Vanderzande, S., Davis, T. M., Mahoney, L. L., Finn, C., & Peace, C. (2020). RosBREED: bridging the chasm between discovery and application to enable DNA-informed breeding in rosaceous crops. Horticulture research, 7(1), 177. https://doi.org/10.1038/s41438-020-00398-7
Iezzoni, Amy F, et al. "RosBREED: bridging the chasm between discovery and application to enable DNA-informed breeding in rosaceous crops." Horticulture research vol. 7,1 (2020): 177. doi: https://doi.org/10.1038/s41438-020-00398-7
Iezzoni AF, McFerson J, Luby J, Gasic K, Whitaker V, Bassil N, Yue C, Gallardo K, McCracken V, Coe M, Hardner C, Zurn JD, Hokanson S, van de Weg E, Jung S, Main D, da Silva Linge C, Vanderzande S, Davis TM, Mahoney LL, Finn C, Peace C. RosBREED: bridging the chasm between discovery and application to enable DNA-informed breeding in rosaceous crops. Hortic Res. 2020 Nov 01;7(1):177. doi: 10.1038/s41438-020-00398-7. PMID: 33328430; PMCID: PMC7603521.
Copy Download .nbib Format: NLM
P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance.

The Journal of experimental medicine

He Y, Gallman AE, Xie C, Shen Q, Ma J, Wolfreys FD, Sandy M, Arsov T, Wu X, Qin Y, Zhang P, Jiang S, Stanley M, Wu P, Tan J, Ding H, Xue H, Chen W, Xu J, Criswell LA, Nititham J, Adamski M, Kitching AR, Cook MC, Cao L, Shen N, Cyster JG, Vinuesa CG.
PMID: 34889940
J Exp Med. 2022 Jan 03;219(1). doi: 10.1084/jem.20211004. Epub 2021 Dec 10.

B cell self-tolerance is maintained through multiple checkpoints, including restraints on intracellular signaling and cell trafficking. P2RY8 is a receptor with established roles in germinal center (GC) B cell migration inhibition and growth regulation. Somatic P2RY8 variants are common...

Cite
He Y, Gallman AE, Xie C, et al. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. J Exp Med. 2021;219(1)doi: 10.1084/jem.20211004.
He, Y., Gallman, A. E., Xie, C., Shen, Q., Ma, J., Wolfreys, F. D., Sandy, M., Arsov, T., Wu, X., Qin, Y., Zhang, P., Jiang, S., Stanley, M., Wu, P., Tan, J., Ding, H., Xue, H., Chen, W., Xu, J., Criswell, L. A., Nititham, J., Adamski, M., Kitching, A. R., Cook, M. C., Cao, L., Shen, N., Cyster, J. G., & Vinuesa, C. G. (2022). P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. The Journal of experimental medicine, 219(1), . https://doi.org/10.1084/jem.20211004
He, Yuke, et al. "P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance." The Journal of experimental medicine vol. 219,1 (2022). doi: https://doi.org/10.1084/jem.20211004
He Y, Gallman AE, Xie C, Shen Q, Ma J, Wolfreys FD, Sandy M, Arsov T, Wu X, Qin Y, Zhang P, Jiang S, Stanley M, Wu P, Tan J, Ding H, Xue H, Chen W, Xu J, Criswell LA, Nititham J, Adamski M, Kitching AR, Cook MC, Cao L, Shen N, Cyster JG, Vinuesa CG. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. J Exp Med. 2022 Jan 03;219(1). doi: 10.1084/jem.20211004. Epub 2021 Dec 10. PMID: 34889940; PMCID: PMC8669517.
Copy Download .nbib Format: NLM
Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members.

European journal of human genetics : EJHG

Finn KS, Pacyna J, Azevedo Tsou C, Jewel Samadder N, Sharp R.
PMID: 33867528
Eur J Hum Genet. 2021 Apr 19; doi: 10.1038/s41431-021-00890-1. Epub 2021 Apr 19.

While prior studies have largely focused on family communication of diagnostic single-gene test results or specific types of cancer testing results, far less work has investigated family communication of cancer-related genetic results that include multi-gene panels, a broad array...

Cite
Finn KS, Pacyna J, Azevedo Tsou C, et al. Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members. Eur J Hum Genet. 2021;doi: 10.1038/s41431-021-00890-1.
Finn, K. S., Pacyna, J., Azevedo Tsou, C., Jewel Samadder, N., & Sharp, R. (2021). Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members. European journal of human genetics : EJHG, . https://doi.org/10.1038/s41431-021-00890-1
Finn, Kelsey Stuttgen, et al. "Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members." European journal of human genetics : EJHG vol. (2021). doi: https://doi.org/10.1038/s41431-021-00890-1
Finn KS, Pacyna J, Azevedo Tsou C, Jewel Samadder N, Sharp R. Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members. Eur J Hum Genet. 2021 Apr 19; doi: 10.1038/s41431-021-00890-1. Epub 2021 Apr 19. PMID: 33867528.
Copy Download .nbib Format: NLM
Human impacts and Anthropocene environmental change at Lake Kutubu, a Ramsar wetland in Papua New Guinea.

Proceedings of the National Academy of Sciences of the United States of America

Long KE, Schneider L, Connor SE, Shulmeister N, Finn J, Roberts GL, Zawadzki A, Enge TG, Smol JP, Ballard C, Haberle SG.
PMID: 34580209
Proc Natl Acad Sci U S A. 2021 Oct 05;118(40). doi: 10.1073/pnas.2022216118.

The impacts of human-induced environmental change that characterize the Anthropocene are not felt equally across the globe. In the tropics, the potential for the sudden collapse of ecosystems in response to multiple interacting pressures has been of increasing concern...

Cite
Long KE, Schneider L, Connor SE, et al. Human impacts and Anthropocene environmental change at Lake Kutubu, a Ramsar wetland in Papua New Guinea. Proc Natl Acad Sci U S A. 2021;118(40)doi: 10.1073/pnas.2022216118.
Long, K. E., Schneider, L., Connor, S. E., Shulmeister, N., Finn, J., Roberts, G. L., Zawadzki, A., Enge, T. G., Smol, J. P., Ballard, C., & Haberle, S. G. (2021). Human impacts and Anthropocene environmental change at Lake Kutubu, a Ramsar wetland in Papua New Guinea. Proceedings of the National Academy of Sciences of the United States of America, 118(40), . https://doi.org/10.1073/pnas.2022216118
Long, Kelsie E, et al. "Human impacts and Anthropocene environmental change at Lake Kutubu, a Ramsar wetland in Papua New Guinea." Proceedings of the National Academy of Sciences of the United States of America vol. 118,40 (2021). doi: https://doi.org/10.1073/pnas.2022216118
Long KE, Schneider L, Connor SE, Shulmeister N, Finn J, Roberts GL, Zawadzki A, Enge TG, Smol JP, Ballard C, Haberle SG. Human impacts and Anthropocene environmental change at Lake Kutubu, a Ramsar wetland in Papua New Guinea. Proc Natl Acad Sci U S A. 2021 Oct 05;118(40). doi: 10.1073/pnas.2022216118. PMID: 34580209; PMCID: PMC8501871.
Copy Download .nbib Format: NLM
A Patient-Specific Computational Framework for the Argus II Implant.

IEEE open journal of engineering in medicine and biology

Finn KE, Zander HJ, Graham RD, Lempka SF, Weiland JD.
PMID: 33748766
IEEE Open J Eng Med Biol. 2020;1:190-196. doi: 10.1109/ojemb.2020.3001563. Epub 2020 Jun 11.

GOAL: Retinal prosthesis performance is limited by the variability of elicited phosphenes. The stimulating electrode's position with respect to retinal ganglion cells (RGCs) affects both perceptual threshold and phosphene shape. We created a modeling framework incorporating patient-specific anatomy and...

Cite
Finn KE, Zander HJ, Graham RD, et al. A Patient-Specific Computational Framework for the Argus II Implant. IEEE Open J Eng Med Biol. 2020;1:190-196doi: 10.1109/ojemb.2020.3001563.
Finn, K. E., Zander, H. J., Graham, R. D., Lempka, S. F., & Weiland, J. D. (2020). A Patient-Specific Computational Framework for the Argus II Implant. IEEE open journal of engineering in medicine and biology, 1190-196. https://doi.org/10.1109/ojemb.2020.3001563
Finn, Kathleen E, et al. "A Patient-Specific Computational Framework for the Argus II Implant." IEEE open journal of engineering in medicine and biology vol. 1 (2020): 190-196. doi: https://doi.org/10.1109/ojemb.2020.3001563
Finn KE, Zander HJ, Graham RD, Lempka SF, Weiland JD. A Patient-Specific Computational Framework for the Argus II Implant. IEEE Open J Eng Med Biol. 2020;1:190-196. doi: 10.1109/ojemb.2020.3001563. Epub 2020 Jun 11. PMID: 33748766; PMCID: PMC7971167.
Copy Download .nbib Format: NLM
Showing 577 to 584 of 584 entries